Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Mouse (Murine) COL4a3 Antikörper:
anti-Rat (Rattus) COL4a3 Antikörper:
anti-Human COL4a3 Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Polyclonal COL4a3 Primary Antibody für IHC, ELISA - ABIN347487
Thevenard, Ramont, Mir, Dupont-Deshorgue, Maquart, Monboisse, Brassart-Pasco: A new anti-tumor strategy based on in vivo tumstatin overexpression after plasmid electrotransfer in muscle. in Biochemical and biophysical research communications 2013
Show all 2 Pubmed References
Horse (Equine) Polyclonal COL4a3 Primary Antibody für WB - ABIN611343
Arcaro, Volinia, Zvelebil, Stein, Watton, Layton, Gout, Ahmadi, Downward, Waterfield: Human phosphoinositide 3-kinase C2beta, the role of calcium and the C2 domain in enzyme activity. in The Journal of biological chemistry 1999
Human Polyclonal COL4a3 Primary Antibody für ICC, IF - ABIN4363552
Jeruschke, Jeruschke, DiStasio, Karaterzi, Büscher, Nalbant, Klein-Hitpass, Hoyer, Weiss, Stottmann, Weber: Everolimus Stabilizes Podocyte Microtubules via Enhancing TUBB2B and DCDC2 Expression. in PLoS ONE 2015
Report monoclonal antibody against the collagen type IV (zeige COL4 Antikörper) alpha3NC1 domain as a marker for glomerular disease.
Data show that deletion of tumstatin and TSP1 (zeige GZMA Antikörper) in p53 (zeige TP53 Antikörper)-/- mice leads to increased tumor burden and reduced survival.
the pathogenetic role of USAG-1 (zeige SOSTDC1 Antikörper) in Col4a3-/- mice might involve crosstalk between kidney tubules and the glomerulus and that inhibition of USAG-1 (zeige SOSTDC1 Antikörper) may be a promising therapeutic approach for the treatment of Alport syndrome.
Collagen alpha3(IV) nor alpha4(IV) were detected in the lens capsule 2 weeks postnatal.
Matrix metalloproteinase-9 (zeige MMP9 Antikörper) generated fragments of procollagen, type IV, alpha 3 has endogenous function as integrin-mediated suppressors of pathologic angiogenesis and tumor growth.
Alpha3(IV), alpha4(IV), and alpha5(IV) chains form a complex, which is a heterotrimer, and a defect in complex formation might be one of the molecular mechanisms underlying the pathogenesis of Alport syndrome.
CCR1-mediated recruitment and local activation of macrophages contribute to disease progression in COL4A3-deficient mice. CCR1 is potential therapeutic target for Alport disease or other progressive nephropathies with interstitial macrophage infiltrates.
Upregulation of Lama5 (zeige LAMA5 Antikörper) transcription and concentration of laminin alpha1 and alpha5 within (Alport)collagen alpha3(IV) knockout glomerular basement membrane thickenings contribute to abnormal permeabilities.
A single immunization of highly denatured recombinant mouse collagen IV (zeige COL4 Antikörper) alpha 3 chain noncollagen domain induces severe glomerulonephritis in 100% of Wistar Kyoto rats.
Alport syndrome is the result of mutations in any of three type IV collagen (zeige COL4 Antikörper) genes, COL4A3, COL4A4 (zeige Col4a4 Antikörper), or COL4A5 (zeige COL4a5 Antikörper). Because the three collagen chains form heterotrimers, there is an absence of all three proteins in the basement membranes where they are expressed. (Review)
These findings indicate that the heterozygous mutations in COL4A3 or COL4A4 (zeige Col4a4 Antikörper) may cause ESRD on their own, although secondary factors, such as environmental factors or unknown genetic changes, might also contribute to the phenotype of kidney disease in patients with ADAS (zeige AGPS Antikörper).
This study indicates that in our population, the COL4A3 rs55703767 polymorphism decreased the risk of KC. However, the TIMP-1 (zeige TIMP1 Antikörper) rs6609533 polymorphism was associated with an increased risk of KC.
mutations in COL4A3, COL4A4 (zeige Col4a4 Antikörper), and COL4A5 (zeige COL4a5 Antikörper) in Chinese patients with Alport Syndrome
COL4A3 gene expression is negatively regulated by ZEB1 (zeige ZEB1 Antikörper) binding to E2 box motifs in the COL4A3 promoter region.
COL4A3 expression is significantly downregulated in human masticatory mucosa during wound healing
New COL4A3 mutations among Portuguese patients with collagen IV (zeige COL4 Antikörper)-related nephropathies were identified in 18 unrelated families.
The results support the hypothesis that certain hypomorphic podocin variants may act as adverse genetic modifiers when co-inherited with COL4A3 mutations
Letter/Case Report: novel COL4A3 gene mutations in a consanguineous family with autosomal recessive Alport syndrome.
we identified seven families with associated mutations in COL4A3 and COL4A4 (zeige Col4a4 Antikörper) genes and four families with associated mutations in COL4A4 (zeige Col4a4 Antikörper) and COL4A5 (zeige COL4a5 Antikörper). We did not find kindreds with digenic inheritance attributable to mutations in COL4A3 and COL4A5 (zeige COL4a5 Antikörper)
Type IV collagen, the major structural component of basement membranes, is a multimeric protein composed of 3 alpha subunits. These subunits are encoded by 6 different genes, alpha 1 through alpha 6, each of which can form a triple helix structure with 2 other subunits to form type IV collagen. This gene encodes alpha 3. In the Goodpasture syndrome, autoantibodies bind to the collagen molecules in the basement membranes of alveoli and glomeruli. The epitopes that elicit these autoantibodies are localized largely to the non-collagenous C-terminal domain of the protein. A specific kinase phosphorylates amino acids in this same C-terminal region and the expression of this kinase is upregulated during pathogenesis. This gene is also linked to an autosomal recessive form of Alport syndrome. The mutations contributing to this syndrome are also located within the exons that encode this C-terminal region. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter.
type IV collagen alpha 3 chain
, collagen alpha-3(IV) chain
, collagen type IV alpha3 chain
, procollagen, type IV, alpha 3
, collagen, type IV, alpha 3 (Goodpasture antigen)
, collagen IV, alpha-3 polypeptide